ES8202549A1 - Un procedimiento para la preparacion de nuevos compuestos antihipercolesteremicos - Google Patents

Un procedimiento para la preparacion de nuevos compuestos antihipercolesteremicos

Info

Publication number
ES8202549A1
ES8202549A1 ES499077A ES499077A ES8202549A1 ES 8202549 A1 ES8202549 A1 ES 8202549A1 ES 499077 A ES499077 A ES 499077A ES 499077 A ES499077 A ES 499077A ES 8202549 A1 ES8202549 A1 ES 8202549A1
Authority
ES
Spain
Prior art keywords
hydroxy
same
acid form
formula
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES499077A
Other languages
English (en)
Spanish (es)
Other versions
ES499077A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES499077A0 publication Critical patent/ES499077A0/es
Publication of ES8202549A1 publication Critical patent/ES8202549A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/62—Unsaturated compounds containing ether groups, groups, groups, or groups containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
ES499077A 1980-02-04 1981-02-03 Un procedimiento para la preparacion de nuevos compuestos antihipercolesteremicos Expired ES8202549A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11804880A 1980-02-04 1980-02-04
US06/175,459 US4282155A (en) 1980-02-04 1980-08-05 Antihypercholesterolemic compounds

Publications (2)

Publication Number Publication Date
ES499077A0 ES499077A0 (es) 1982-02-01
ES8202549A1 true ES8202549A1 (es) 1982-02-01

Family

ID=26815915

Family Applications (1)

Application Number Title Priority Date Filing Date
ES499077A Expired ES8202549A1 (es) 1980-02-04 1981-02-03 Un procedimiento para la preparacion de nuevos compuestos antihipercolesteremicos

Country Status (8)

Country Link
US (1) US4282155A (enExample)
EP (1) EP0033536B1 (enExample)
DE (1) DE3165894D1 (enExample)
DK (1) DK46081A (enExample)
ES (1) ES8202549A1 (enExample)
GR (1) GR73078B (enExample)
IE (1) IE51476B1 (enExample)
PT (1) PT72393B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4351844A (en) * 1980-02-04 1982-09-28 Merck & Co., Inc. Hypocholesterolemic hydrogenation products and process of preparation
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Ｍｂ−５３０ａ誘導体
JPS56150037A (en) * 1980-04-22 1981-11-20 Sankyo Co Ltd Hydronaphthalene compound
US4343814A (en) * 1980-11-17 1982-08-10 Merck & Co., Inc. Hypocholesterolemic fermentation products
US4440927A (en) * 1981-06-19 1984-04-03 Merck & Co., Inc. Process for preparing inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase via a chiral synthon
US4490546A (en) * 1982-03-25 1984-12-25 Merck & Co., Inc. Process for 4a'(R),5'-dihydromevinolin
US4499289A (en) * 1982-12-03 1985-02-12 G. D. Searle & Co. Octahydronapthalenes
US4503072A (en) * 1982-12-22 1985-03-05 Merck & Co., Inc. Antihypercholesterolemic compounds
US4950775A (en) * 1985-10-11 1990-08-21 University Of California Antihypercholesterolemic compounds and synthesis thereof
US5208258A (en) * 1985-10-11 1993-05-04 The Regents Of The University Of California Antihypercholesterolemic compounds and synthesis thereof
US4841074A (en) * 1987-12-11 1989-06-20 Merck & Co., Inc. Intermediates and processes for 6-carboxy HMG-CoA reductase inhibitors
US4900754A (en) * 1987-12-21 1990-02-13 Rorer Pharmaceutical Corp. HMG-COA reductase inhibitors
US4994494A (en) * 1987-12-21 1991-02-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. HMG-COA reductase inhibitors
US5001144A (en) * 1987-12-21 1991-03-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors
US4863957A (en) * 1987-12-21 1989-09-05 Rorer Pharmaceutical Corporation Novel HMG-CoA reductase inhibitors
US4939143A (en) * 1987-12-21 1990-07-03 Rorer Pharmaceutical Corporation Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors
US4904691A (en) * 1987-12-21 1990-02-27 Rorer Pharmaceutical Corporation Novel HMG-CoA reductase inhibitors
US5001128A (en) * 1987-12-21 1991-03-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. HMG-COA reductase inhibitors
US4904692A (en) * 1987-12-21 1990-02-27 Rorer Pharmaceutical Corporation Novel HMG-CoA reductase inhibitors
US5132312A (en) * 1989-03-27 1992-07-21 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US4992429A (en) * 1989-08-24 1991-02-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Novel HMG-COA reductase inhibitors
US4946860A (en) * 1989-11-03 1990-08-07 Rorer Pharmaceutical Corporation Benzothiopyranyl derivatives as HMG-CoA reductase inhibitors
WO1991013616A1 (en) * 1990-03-08 1991-09-19 Rorer International (Overseas) Inc. NOVEL HMG-CoA REDUCTASE INHIBITORS
US5443771A (en) * 1992-09-15 1995-08-22 Gupta; Sankar D. Ceramic fibre and process therefor
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US6391583B1 (en) 1998-12-18 2002-05-21 Wisconsin Alumni Research Foundation Method of producing antihypercholesterolemic agents
SK282679B6 (sk) * 1999-04-16 2002-11-06 Biotika, A. S. Spôsob izolácie lovastatínu z vyfermentovanej pôdy
IN192861B (enExample) 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
BR0307944A (pt) * 2002-02-25 2005-02-01 Kudos Pharm Ltd Piranonas úteis como inibidores de atm
CN103012344B (zh) * 2011-09-28 2014-11-12 北大方正集团有限公司 从洛伐他汀结晶母液中回收洛伐他汀的方法
CN102875505B (zh) * 2012-08-02 2015-08-05 丽珠集团新北江制药股份有限公司 一种美伐他汀的提取精制工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049495A (en) * 1974-06-07 1977-09-20 Sankyo Company Limited Physiologically active substances and fermentative process for producing the same
JPS5612114B2 (enExample) * 1974-06-07 1981-03-18
DE2748825C2 (de) * 1976-11-02 1986-11-27 Sankyo Co., Ltd., Tokio/Tokyo Substituierte 3,5-Dihydroxyheptansäurederivate und diese enthaltende Arzneimittel gegen Hyperlipämie
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
IL60219A (en) * 1979-06-15 1985-05-31 Merck & Co Inc Hypocholesteremic fermentation products of the hmg-coa reductase inhibitor type,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0033536A2 (en) 1981-08-12
ES499077A0 (es) 1982-02-01
GR73078B (enExample) 1984-01-31
EP0033536A3 (en) 1982-02-24
DK46081A (da) 1981-08-05
PT72393A (en) 1981-02-01
IE51476B1 (en) 1987-01-07
PT72393B (en) 1982-09-06
DE3165894D1 (en) 1984-10-18
EP0033536B1 (en) 1984-09-12
US4282155A (en) 1981-08-04
IE810167L (en) 1981-08-04

Similar Documents

Publication Publication Date Title
ES8202549A1 (es) Un procedimiento para la preparacion de nuevos compuestos antihipercolesteremicos
ES8609296A1 (es) Un procedimiento para la preparacion de un compuesto
BE853867A (fr) Procede de transformation d'un ester d'acide chiral d'alcool secondaire alpha-cyane optiquement actif de structure (r) en ester d'acide chiral d'alcool secondaire alpha-cyane de structure (s)
EP0613883A4 (en) HYDROXAMIC ACID DERIVATIVE.
ES8705842A1 (es) Procedimiento para la preparacion biotecnologica de acidos alfa-arilalcanoicos activos opticamente
BE853866A (fr) Procede de transformation d'un ester d'acide chiral d'alcool secondaire alpha-cyane optiquement actif en ester d'acide chiral d'alcool secondaire alpha-cyane
ES2101583T3 (es) Esteres de acido sulfurico con alcoholes de azucar para el tratamiento de cambios arterioescleroticos en las paredes vasculares.
NO911880D0 (no) Derivater av biologisk aktive molekyler, samt analysesettfor bestemmelse av mediatorer.
SE7900150L (sv) Insekticida estrar av optiskt aktiv, substituerad ettiksyra och racemisk eller optiskt aktiv, substituerad bensylalkohol, sett for framstellning derav och insekticida kompositioner innehallande dessa estrar
SE8102254L (sv) Foreningar, som hemmar kolesterolbiosyntes, och framstellning derav
ES480147A1 (es) Un procedimiento para la preparacion de derivados del acido pseudomonico.
SE8100846L (sv) Antirinovirusmedel
ES8101592A1 (es) Un procedimiento para la preparacion del acido 7-oxo-1-aza- biciclo (3.2.0)hept-2-en-2-carboxilico
DE3271901D1 (en) Heterocyclic compounds useful as pesticides and processes for making them
ATE39487T1 (de) Ml-236b-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3265503D1 (en) Bis-esters of alkanediols, pharmaceutical compositions thereof and intermediates therefor
JPS523046A (en) Prepration of 4-homotwistane-3-carboxylic acid esters
EG15293A (en) Optically active isomers of trans-3-(2-chloro-2-(4-chloro-phenyl)-vinyl)-2-2-dimethyl-cyclopropane-1-carboxylic acid-cyano-4-fluoro-3-phenoxy-penzyl esters,a process for their preparation and their use
DE3161634D1 (en) Alkyl-4-methyl-3-formyl pentenoates, their preparation, their use in the preparation of the 4-methyl-3-formyl-3-pentenoic acid and the intermediates
IT1137492B (it) Composti ad attivita' gaba simile,procedimento per prepararli e composizioni farmaceutiche che li comprendono
FR2382901A1 (enExample)
IL57433A (en) Pharmaceutical compositions containing cyclopentane derivatives
FR2429781A1 (fr) Esters d'acides dihalogenevinyl-cyclopropane-thioliques, procede pour leur preparation et leur application dans la lutte anti-parasitaire
JPS55133304A (en) Perfume controller
DE69019591D1 (de) Phospholipase-A2-Inhibitor, Verfahren zu seiner Herstellung und diesen enthaltende pharmazeutische oder veterinäre Zusammensetzungen.

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960401